Researcher Dr Jodi Watt is to examine thousands of magnetic resonance imaging (MRI) brain scans to identify patterns of brain health. Based at the Glasgow Royal Infirmary, Dr Watt will be using the UK Biobank Cohort and the European Prevention of Alzheimer\u2019s Dementia (EPAD) cohort for her exciting postdoctoral project.
DPUK Director Professor John Gallacher has co-signed an open letter to the UK prime minister, published by the Sunday Times, calling for greater investment in dementia research, taking inspiration from the COVID-19 vaccines effort.
A new study by a DPUK-funded researcher has provided evidence that cognitive frailty is a feature of unhealthy yet normal ageing, rather than a sign of impending dementia.
A team of researchers has developed the first model for prescribing personalised medication to treat dementia. The model uses artificial intelligence (AI) to determine the most effective dementia medication for an individual based on factors such as their age, sex, and memory assessment scores.
A new study co-authored by a DPUK-funded researcher has found that people with type-2 diabetes have worse overall brain health than people with high blood pressure, and that those with both conditions have even poorer brain health.
A new study has found that hearing loss increases the risk of a precursor to dementia called mild cognitive impairment \u2013 but this increased risk is not present in people who wear hearing aids.
Previous research has found an inconsistent relationship with dementia and benzodiazepines \u2013 a group of sedative drugs used to treat conditions such as anxiety and insomnia. Now, using the DPUK Data Portal, a team of researchers in France has investigated the association further and found compelling evidence that benzodiazepines reduce some of the hallmarks of Alzheimer\u2019s disease.
Dementias Platform UK has been awarded a \u00a323,000 grant from Alzheimer\u2019s Research UK\u2019s Inspire Fund, which supports public engagement initiatives to improve understanding of dementia and dementia research.
A team of UK researchers has been investigating the association between prescription medications and dementia using a dataset funded by Dementias Platform UK (DPUK).
Brain waves provide an insight into brain cell activity, but they are notoriously difficult to isolate and analyse. Now, a PhD candidate at the University of Oxford has developed a new method to help researchers study brain waves that has exciting implications for detecting and treating dementia.
DPUK's all-new Spring Academy is a week-long series of lectures, presentations and guided tutorials giving researchers an introduction to cohort data analysis techniques.
With an effective treatment for dementia proving notoriously elusive, recent years have seen an increasing focus on secondary prevention \u2013 detecting and treating those at high risk or in preclinical stages of the disease as early as possible to reduce its impact. Now, a new review summarises the landscape of secondary prevention of dementia and outlines what needs to happen next.
A study conducted in DPUK\u2019s Data Portal has found that people who have high blood pressure (known scientifically as hypertension) tend to have significantly smaller brain volumes and perform worse in mental tests.
DPUK is delighted to support the launch of Dementias Platform Australia (DPAU), a new initiative enabling access to research data from dementia studies carried out in Australia, the Asia-Pacific region and beyond.
DPUK's all-new Autumn Academy is a week-long series of lectures, presentations and group workshops giving researchers in-depth insight into cohort data analysis techniques.
![\"A](\"https://www.dementiasplatform.uk/news-and-media/latest-news/new-study-begins-measuring-brain-scans-to-score-brain-health/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n